|
| Home : GeneLeap Presents New Preclinical Data for Hydrogel Encapsulated TLR9 Agonist at AACR 2021 |
|
Apr 14
2021 |
GeneLeap Presents New Preclinical Data for Hydrogel Encapsulated TLR9 Agonist at AACR 2021 |
|
BOSTON, April 14, 2021 /PRNewswire/ -- GeneLeap Bio., a subsidiary of Luye Life Sciences specializing in the development of nucleic acid therapeutics, presented an ePoster entitled 'Hydrogel encapsulated TLR9 agonists show sustained tumor growth inhibition and prolong survival of CT26... |
|
|
|
| Source:https://www.prnewswire.com:443/news-releases/geneleap-presents-new-preclinical-data-for-hydrogel-encapsulated-tlr9-agonist-at-aacr-2021-301268488.html |
| |
|
Related News
|
» SGS Expert Looks at the Growing Market in Connected Vehicles
» XNK Therapeutics appoints Dr. Johan Aschan as Chief Medical Officer
|
|
|
